Global X Genomics & Biotechnology ETF
GNOM
48 hedge funds and large institutions have $27.4M invested in Global X Genomics & Biotechnology ETF in 2026 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 1 closing their positions.
1,000% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 1
97% more capital invested
Capital invested by funds: $13.9M → $27.4M (+$13.5M)
20% more funds holding
Funds holding: 40 → 48 (+8)
10.35% more ownership
Funds ownership: 27.77% → 38.11% (+10%)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$4.44M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.07M |
| 3 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$776K |
| 4 |
FIA
Foundations Investment Advisors
Phoenix,
Arizona
|
+$525K |
| 5 |
SH
SLT Holdings
Scottsdale,
Arizona
|
+$525K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$330K |
| 2 |
AA
Armis Advisers
Atlanta,
Georgia
|
-$244K |
| 3 |
Jane Street
New York
|
-$215K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$48.8K |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$37.9K |
GNOM Hedge Fund Activity: Q2 2026 in Review
48 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q2 2026, worth a combined $27.4M — up 97% from $13.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GNOM positions and 1 closed out — a net gain of 10 holders — while 10 added to existing stakes and 12 trimmed.
The largest buyer was Sumitomo Mitsui Trust Group, opening a new position worth an estimated $4.44M. The largest seller was Bank of America, cutting an estimated $330K.
- 48 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q2 2026, up from 40 in Q1 2026.
- Funds reported $27.4M of Global X Genomics & Biotechnology ETF stock for Q2 2026, up 97% quarter-over-quarter.
- 11 funds opened new Global X Genomics & Biotechnology ETF positions in Q2 2026 and 1 closed out, a net change of +10 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q2 2026 was Sumitomo Mitsui Trust Group, an estimated $4.44M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q2 2026 was Bank of America, an estimated $330K sold.
Based on aggregated 13F filings for Q2 2026.